Evidence map›Paper›PMID 26887530›Full record

ArticleScientific reports2016

Conserved miR-26b enhances ovarian granulosa cell apoptosis through HAS2-HA-CD44-Caspase-3 pathway by targeting HAS2.

Jiying Liu, Fei Tu, Wang Yao, Xinyu Li, Zhuang Xie, Honglin Liu, Qifa Li, Zengxiang Pan

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jiying LiuCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, People's Republic of China.
Fei TuCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, People's Republic of China.
Wang YaoCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, People's Republic of China.
Xinyu LiCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, People's Republic of China.
Zhuang XieCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, People's Republic of China.
Honglin LiuCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, People's Republic of China.
Qifa LiCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, People's Republic of China.
Zengxiang PanCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, People's Republic of China.
Nanjing Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hyaluronan synthase 2 (HAS2)-hyaluronic acid (HA)-CD44-Caspase-3 pathway is involved in ovarian granulosa cell (GC) functions in mammals. HAS2 is a key enzyme required for HA synthesis and is the key factor in this pathway. However, the regulation of HAS2 and the HAS2-mediated pathway by microRNAs in GCs is poorly understood. Here, we report that miR-26b regulates porcine GC (pGC) apoptosis through the HAS2-HA-CD44-Caspase-3 pathway by binding directly to the 3'- untranslated region of HAS2 mRNA. Knockdown of miR-26b reduced pGC apoptosis. Luciferase reporter assays demonstrated that HAS2 is a direct target of miR-26b in pGCs. Knockdown and overexpression of miR-26b increased and decreased, respectively, HA content, and HAS2 and CD44 expression in pGCs. At the same time, inhibition and overexpression of miR-26b decreased and increased the expression of Caspase-3, a downstream factor in the HAS2-HA-CD44 pathway. Moreover, knockdown of HAS2 enhanced pGC apoptosis, reduced the inhibitory effects of a miR-26b inhibitor on pGC apoptosis, repressed HA content and CD44 expression, and promoted Caspase-3 expression. In addition, overexpression of HAS2 has a opposite effect. Collectively, miR-26b positively regulates pGC apoptosis via a novel HAS2-HA-CD44-Caspase-3 pathway by targeting the HAS2 gene.

Indexed as

AnimalsApoptosisCaspase 3FemaleGlucuronosyltransferaseGranulosa CellsHeLa CellsHumansHyaluronan ReceptorsHyaluronic AcidMicroRNAsSwineCaspase 3GlucuronosyltransferaseHyaluronan ReceptorsHyaluronic AcidMicroRNAs

Identifiers

PMID26887530
PMCPMC4758074
OpenAlexW2279085311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.